Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice

Transplantation

Volumn 87, Issue 11, 2009, Pages 1654-1658

  Ito, Ryoji ^a   Katano, Ikumi ^a   Kawai, Kenji ^a   Hirata, Hiroshi ^a   Ogura, Tomoyuki ^a   Kamisako, Tsutomu ^a   Eto, Tomoo ^a   Ito, Mamoru ^a  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Immunodeficient mice; Model animals; Xeno GVHD

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SCID MOUSE; WHOLE BODY RADIATION;

ANIMALS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIVER; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 67649580473     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a5cb07     Document Type: Article

References (28)

1. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: Pathobiology and management. Exp Hematol 2001; 29: 259.
2. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527.
3. McCune JM, Namikawa R, Kaneshima H, et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632.
4. Mosier DE, Gulizia RJ, Baird SM, et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256.
5. Hoffmann-Fezer G, Gall C, Zengerle U, et al. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993; 81: 3440.
6. Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today 1995; 16: 529.
7. AbediMR,Christensson B, Islan KB, et al. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur J Immunol 1992; 22: 823.
8. Carballido JM, Namikawa R, Carballido-Perrig N, et al. Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice. Nat Med 2000; 6: 103.
9. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180.
10. Greiner DL, Shultz LD, Yates J, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17- scid/scid mice. Am J Pathol 1995; 146: 888.
11. Sandhu JS, Gorczynski R, Shpitz B, et al. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation 1995; 60: 179.
12. Tsuchida M, Brown SA, Tutt LM, et al. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Clin Transplant 1997; 11(5 Pt 2): 522.
13. Martino G, Anastasi J, Feng J, et al. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol1993; 23: 1023.
14. van Rijn RS, Simonetti ER, Hagenbeek A, et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/-c-/- double-mutant mice. Blood 2003; 102: 2522.
15. Ohbo K, Suda T, Hashiyama M, et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 1996; 87: 956.
16. Hiramatsu H, Nishikomori R, Heike T, et al. Complete reconstitution of human lymphocytes from cord blood CD34- cells using the NOD/ SCID/gammacnull mice model. Blood 2003; 102: 873.
17. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/SCID/gamma (c) (null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175.
18. Yahata T, Ando K, Nakamura Y, et al. Functional human T lymphocyte development from cord blood CD34- cells in nonobese diabetic/Shiscid, IL-2 receptor gamma null mice. J Immunol 2002; 169: 204.
19. Murphy WJ, Bennett M, Anver MR, et al. Human-mouse lymphoid chimeras: Host-vs.-graft and graft-vs.-host reactions. Eur J Immunol1992; 22: 1421.
20. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5: 347.
21. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754.
22. Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis 2007; 2: 35.
23. Ferrara JL, Cooke KR, Pan L, et al. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996; 14: 473.
24. Schmaltz C, Alpdogan O, Horndasch KJ, et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versushost disease and graft-versus-leukemia effect. Blood 2001; 97: 2886.
25. Schmaltz C, Alpdogan O, Muriglan SJ, et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 2003; 101: 2440.
26. Mutis T, van Rijn RS, Simonetti ER, et al. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Clin Cancer Res 2006; 12: 5520.
27. Bondanza A, Valtolina V, Magnani Z, et al. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 2006; 107: 1828.
28. Fast LD, DiLeone G, Cardarelli G, et al. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graftversus- host disease in Rag2-/-gammac-/- double knockout mice. Transfusion 2006; 46: 1553.